Health Condition 1: K802- Calculus of gallbladder without cholecystitis
Conditions
Interventions
Intervention1: Nalbuphine with levobupivacaine: Patients will receive intrathecal 0.5%levobupivacaine 2ml(10mg) with nalbuphine 0.4ml as an adjuvant for thoracic spinal anaesthesia.
Control Intervent
Sponsors
Rvm Instutute of medical Sciences and research centre
Eligibility
Inclusion criteria
Inclusion criteria: ASA Grade I & II Age 18-60 years daignosised with gall bladder stones
Exclusion criteria
Exclusion criteria: ASA III and above Patients hypersensitive to the drugs Patients with spinal deformities and neurological deficits Patients contraindicated to intrathecal anaesthesia Patients with coagulopathies Patients with local site infections Pregnancy and lactation Unwilling patients
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Onset time and duration of sensory block and motor block following thoracic spinal anaesthesia with nalbuphine or buprenorphine as adjuvants to levobupivacaineTimepoint: at baseline, 2 minutes , 4 minutes, 6minutes, 8minutes,10minutes, 15minutes 30minutes, 45minutes,60minutes,120minutes,180minutes | — |
Secondary
| Measure | Time frame |
|---|---|
| Duration of postoperative analgesiaTimepoint: From completion of surgery to first request for rescue analgesia;Intraoperative hemodynamic variables including heart rate & blood pressureTimepoint: at baseline, 2 minutes , 4 minutes, 6minutes, 8minutes,10minutes, 15minutes 30minutes, 45minutes,60minutes,120minutes,180minutes | — |
Countries
India
Contacts
Public Contactdr show reddy edara
rvm institute of medical sciences and research cente
Outcome results
None listed